{"id":"NCT02861534","sponsor":"Merck Sharp & Dohme LLC","briefTitle":"A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)","officialTitle":"A Randomized Parallel-Group, Placebo-Controlled, Double-Blind, Event-Driven, Multi-Center Pivotal Phase III Clinical Outcome Trial of Efficacy and Safety of the Oral sGC Stimulator Vericiguat in Subjects With Heart Failure With Reduced Ejection Fraction (HFrEF) - VerICiguaT GlObal Study in Subjects With Heart Failure With Reduced EjectIon FrAction (VICTORIA)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2016-09-20","primaryCompletion":"2019-06-18","completion":"2019-09-02","firstPosted":"2016-08-10","resultsPosted":"2020-06-29","lastUpdate":"2021-11-15"},"enrollment":5050,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Heart Failure","Chronic Heart Failure With Reduced Ejection Fraction"],"interventions":[{"type":"DRUG","name":"Vericiguat","otherNames":["MK-1242"]},{"type":"DRUG","name":"Placebo for vericiguat","otherNames":[]}],"arms":[{"label":"Vericiguat","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"This is a randomized, placebo-controlled, parallel-group, multi-center, double-blind, event driven study of vericiguat (MK-1242) in participants with heart failure with reduced ejection fraction (HFrEF). The primary hypothesis is vericiguat (MK-1242) is superior to placebo in increasing the time to first occurrence of the composite of cardiovascular (CV) death or heart failure (HF) hospitalization in participants with HFrEF.","primaryOutcome":{"measure":"Time to First Occurrence of Composite Endpoint of Cardiovascular (CV) Death or Heart Failure (HF) Hospitalization","timeFrame":"Up to approximately 33 months (through primary analysis database cutoff date of 18-June-2019)","effectByArm":[{"arm":"Vericiguat","deltaMin":33.6,"sd":null},{"arm":"Placebo","deltaMin":37.8,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.019"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":25},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":["31820546","40885377","38934967","38363272","37671551","37565973","37503602","37417824","37331690","37137660","36049817","35880474","35791083","35656822","34743540","34432985","34407626","34217593","34216757","33185650","33039447","32222134","29032136"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":852,"n":2519},"commonTop":["Hypotension","Dizziness","Cardiac failure","Anaemia","Dyspnoea"]}}